• Home
  • About
  • Investors
  • Science
  • Announcements
cardiogeni.com

Announcements

Cardiogeni PLC – Board Appointment of (Lord) James Nicholas Bethell

Aug 29, 2025
Read More

Cardiogeni PLC – Details of Advanced Subscription & Company Update

Jul 24, 2025
Read More

Cardiogeni PLC – £150,000 Advanced Subscription Agreement

Jul 24, 2025
Read More

Cardiogeni PLC – Appointment of corporate broker

Jul 2, 2025
Read More

Cardiogeni PLC – TR-1: Notification of major holdings

Jun 3, 2025
Read More

Cardiogeni PLC – £650,000 Placing at 17.3p per share

May 22, 2025
Read More

Cardiogeni PLC – Formation of UAE joint venture company

May 6, 2025
Read More

Cardiogeni PLC – Update on JV including £20m Funding

Apr 1, 2025
Read More

Cardiogeni PLC – Director’s Dealings

Feb 28, 2025
Read More

Cardiogeni PLC – £20M MoU for Funding Clinical Development in UAE

Feb 10, 2025
Read More
Older EntriesNext Entries
Cardiogeni is committed to advancing pioneering cellular therapies that repair and reactivate heart tissue leading to improved heart health. Guided by world-leading science, commercial excellence and a dedication to patient impact, we strive to deliver safe, effective, and life-changing solutions for those living with heart failure.

Navigation

  • Home
  • About
  • Investors
  • Science
  • Announcements

Socials

  • Follow

Address

Cardiogeni Plc
Celixir House,
Innovation Way,
Stratford-Upon-Avon,
England,
CV37 7GZ

© 2025 Cardiogeni. All rights reserved.

Terms and Conditions | Privacy Policy

Designed By: